Wat is de prijs voor Hancock Jaffe Laboratories (HJLI)

Het prijs van Hancock Jaffe Laboratories (HJLI) is $10.38

Wat is de marktkapitalisatie voor Hancock Jaffe Laboratories (HJLI)

Marktkapitalisatie voorHancock Jaffe Laboratories (HJLI) is $4.55M

Hancock Jaffe Laboratories (HJLI) K/B-verhouding

Hancock Jaffe Laboratories, Inc. is a medical device company in its developmental stage, specializing in creating advanced tissue-based and biologic solutions. These innovations are engineered to either sustain or significantly enhance the lives of patients afflicted with cardiovascular, peripheral arterial, and venous diseases, as well as end-stage renal disease (ESRD). The firm, headquartered in Irvine, California, maintains a dedicated team of nine full-time employees. Among its key initiatives, the company is actively developing implantable bioprosthetic devices for cardiovascular applications. This includes the Bioprosthetic Heart Valve (BHV), a swine-derived heart valve designed to mimic the function of a native heart valve and provide superior performance compared to current prosthetic options. Furthermore, the company is developing a Venous Valve, another bioprosthetic device sourced from pig tissue. This valve is specifically designed for individuals suffering from chronic venous insufficiency (CVI) in the lower limbs, a condition frequently resulting from damage to leg vein valves after the formation of deep venous blood clots.

Jaar	P/B-ratio	Wijzigen
Niet genoeg gegevens voor de verstrekte datums.

Jaar

P/B-ratio

Wijzigen

Niet genoeg gegevens voor de verstrekte datums.

Bedrijf	P/B-ratio	Verschil in P/B-ratio	Land
Abbott Laboratories ABT.US	3.7944	-	US
Stryker Corporation SYK.US	5.423	-	US
Medtronic plc MDT.US	2.0146	-	IE
Boston Scientific Corporation BSX.US	3.072	-	US
Edwards Lifesciences Corporation EW.US	4.9725	-	US

Bedrijf

P/B-ratio

Verschil in P/B-ratio

Land